
Technology & Science
Liverpool leads groundbreaking clinical trial for deadly parasitic disease
A pioneering clinical trial is currently underway in Liverpool, uniting NHS University Hospitals of Liverpool Group (UHLG), the University of Liverpool (UoL), and the Drugs for Neglected Diseases initiative (DNDi)—a leading international non-profit organisation—in a concerted effort to combat visceral leishmaniasis, one of the world’s most fatal parasitic diseases.